Patients Diabetic | Coronary Artery Disease | Percutaneous Coronary Intervention elective
Item
diabetic patients with coronary artery disease undergoing elective percutaneous coronary intervention
boolean
C0030705 (UMLS CUI [1,1])
C0241863 (UMLS CUI [1,2])
C1956346 (UMLS CUI [2])
C1532338 (UMLS CUI [3,1])
C0439608 (UMLS CUI [3,2])
ST segment elevation myocardial infarction
Item
ongoing st-segment elevation myocardial infarction (mi)
boolean
C1536220 (UMLS CUI [1])
abciximab
Item
administration of abciximab during the previous two weeks
boolean
C0288672 (UMLS CUI [1])
Creatinine measurement, serum
Item
serum creatinine more than 2.5 mg/dl (221 micro-mol/l)
boolean
C0201976 (UMLS CUI [1])
Hemorrhage | Bleeding tendency
Item
ongoing bleeding or bleeding diathesis
boolean
C0019080 (UMLS CUI [1])
C1458140 (UMLS CUI [2])
Cerebrovascular accident
Item
previous stroke in the last six months
boolean
C0038454 (UMLS CUI [1])
Major surgery
Item
major surgery within the previous six weeks
boolean
C0679637 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count <100.000 per cubic mm
boolean
C0032181 (UMLS CUI [1])
Heparin, Low-Molecular-Weight | tirofiban | eptifibatide
Item
subjects who received low-molecular-weight heparin, tirofiban, or eptifibatide within the 10 hours prior to randomization
boolean
C0019139 (UMLS CUI [1])
C0247025 (UMLS CUI [2])
C0253563 (UMLS CUI [3])
Oral anticoagulants | Coumarins | Exception PT-INR Level
Item
subjects on oral anticoagulation medication (coumarin derivatives) within the last 7 days unless pt-inr <1.5 times the control
boolean
C0354604 (UMLS CUI [1])
C0010207 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C1821762 (UMLS CUI [3,2])
C0441889 (UMLS CUI [3,3])